Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Pancreas (All Stages^), 2016-2020

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by CI*Rank
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Recent Trend
Recent 5-Year Trend in Incidence Rates
(95% Confidence Interval)
 sort by trend descending
US (SEER+NPCR) 1 13.2 (13.2, 13.3) N/A 52,045 rising rising trend 1.0 (0.8, 1.1)
District of Columbia 6 14.9 (13.6, 16.3) 1 (1, 33) 103 rising rising trend 1.5 (0.5, 2.7)
New Jersey 7 14.8 (14.5, 15.1) 2 (1, 5) 1,687 rising rising trend 1.2 (0.9, 1.5)
Pennsylvania 6 14.5 (14.3, 14.8) 3 (1, 8) 2,585 rising rising trend 1.4 (1.1, 1.7)
New York 7 14.4 (14.2, 14.6) 4 (1, 9) 3,603 rising rising trend 0.8 (0.7, 0.9)
Louisiana 7 14.2 (13.7, 14.6) 5 (1, 21) 794 rising rising trend 0.8 (0.3, 1.3)
Minnesota 6 14.1 (13.7, 14.5) 6 (2, 22) 975 rising rising trend 3.0 (2.5, 3.6)
Illinois 7 14.1 (13.8, 14.3) 7 (3, 19) 2,193 rising rising trend 1.9 (0.8, 3.3)
Wisconsin 6 14.0 (13.7, 14.4) 8 (2, 23) 1,070 rising rising trend 1.4 (0.9, 1.9)
Massachusetts 7 14.0 (13.6, 14.3) 9 (3, 23) 1,237 rising rising trend 1.0 (0.6, 1.4)
Delaware 6 13.9 (13.0, 14.8) 10 (1, 38) 188 rising rising trend 1.9 (0.8, 3.2)
Connecticut 7 13.9 (13.4, 14.4) 11 (2, 29) 668 stable stable trend 0.1 (-2.3, 0.7)
Michigan 6 13.8 (13.5, 14.1) 12 (5, 26) 1,813 rising rising trend 0.8 (0.5, 1.2)
Mississippi 6 13.7 (13.2, 14.3) 13 (3, 33) 506 falling falling trend -2.2 (-4.7, -0.3)
Ohio 6 13.7 (13.5, 14.0) 14 (6, 26) 2,109 rising rising trend 1.6 (1.2, 2.0)
Maine 6 13.7 (13.0, 14.5) 15 (1, 37) 281 stable stable trend 0.6 (-0.3, 1.5)
Idaho 7 13.7 (13.0, 14.5) 16 (1, 37) 285 rising rising trend 1.4 (0.5, 2.4)
Maryland 6 13.7 (13.3, 14.1) 17 (5, 30) 1,009 rising rising trend 0.9 (0.6, 1.2)
New Hampshire 6 13.6 (12.8, 14.4) 18 (2, 39) 255 rising rising trend 3.8 (0.5, 6.8)
Iowa 7 13.5 (13.0, 14.1) 19 (4, 36) 556 rising rising trend 1.2 (1.0, 1.5)
South Carolina 6 13.5 (13.1, 14.0) 20 (6, 33) 910 stable stable trend -1.6 (-4.9, 1.3)
Rhode Island 6 13.5 (12.7, 14.4) 21 (1, 41) 191 stable stable trend 1.2 (0.0, 2.6)
Hawaii 7 13.5 (12.7, 14.3) 22 (2, 40) 260 rising rising trend 0.6 (0.3, 1.0)
Georgia 7 13.4 (13.1, 13.7) 23 (12, 33) 1,561 rising rising trend 1.2 (0.8, 1.7)
Kentucky 7 13.4 (13.0, 13.8) 24 (7, 36) 759 rising rising trend 1.6 (1.0, 2.3)
Alaska 6 13.3 (12.1, 14.7) 25 (1, 47) 96 stable stable trend 0.5 (-0.5, 1.7)
Washington 5 13.3 (12.9, 13.6) 26 (13, 36) 1,184 rising rising trend 0.9 (0.6, 1.2)
South Dakota 6 13.3 (12.3, 14.3) 27 (2, 45) 148 rising rising trend 1.6 (0.2, 3.2)
North Carolina 6 13.3 (13.0, 13.6) 28 (15, 35) 1,721 rising rising trend 1.4 (1.0, 1.8)
West Virginia 6 13.1 (12.5, 13.8) 29 (7, 41) 342 rising rising trend 1.9 (1.2, 2.6)
Missouri 6 13.1 (12.8, 13.5) 30 (15, 38) 1,040 rising rising trend 0.9 (0.5, 1.5)
Nebraska 6 13.1 (12.4, 13.8) 31 (7, 41) 304 rising rising trend 1.4 (0.6, 2.3)
Alabama 6 13.0 (12.6, 13.5) 32 (16, 39) 824 stable stable trend 0.7 (-2.0, 1.5)
Florida 6 12.9 (12.8, 13.1) 33 (26, 38) 4,119 rising rising trend 1.0 (0.8, 1.4)
Texas 7 12.9 (12.7, 13.1) 34 (26, 39) 3,732 rising rising trend 1.4 (0.9, 2.5)
Oregon 6 12.8 (12.4, 13.3) 35 (19, 41) 703 stable stable trend -2.7 (-5.7, 0.2)
Vermont 6 12.7 (11.7, 13.9) 36 (4, 49) 115 stable stable trend 1.0 (-0.3, 2.4)
Tennessee 6 12.7 (12.4, 13.1) 37 (26, 42) 1,081 stable stable trend 0.7 (-0.8, 1.3)
Virginia 6 12.6 (12.3, 13.0) 38 (28, 42) 1,304 stable stable trend 0.6 (-0.9, 1.2)
Arkansas 6 12.5 (12.0, 13.0) 39 (26, 46) 481 rising rising trend 1.6 (1.1, 2.1)
Montana 6 12.4 (11.6, 13.3) 40 (15, 49) 180 rising rising trend 1.2 (0.2, 2.4)
California 7 12.1 (12.0, 12.3) 41 (38, 45) 5,400 rising rising trend 0.6 (0.4, 0.8)
Oklahoma 6 12.1 (11.6, 12.5) 42 (35, 48) 578 rising rising trend 0.7 (0.3, 1.3)
Arizona 6 12.0 (11.7, 12.3) 43 (38, 48) 1,122 rising rising trend 1.4 (1.0, 1.8)
Kansas 6 11.8 (11.3, 12.3) 44 (37, 49) 420 rising rising trend 1.3 (0.7, 1.9)
North Dakota 6 11.7 (10.7, 12.7) 45 (26, 49) 106 stable stable trend 0.6 (-0.3, 1.6)
Colorado 6 11.6 (11.3, 12.0) 46 (40, 49) 739 rising rising trend 0.5 (0.1, 1.0)
New Mexico 7 11.6 (11.0, 12.2) 47 (39, 49) 317 rising rising trend 0.5 (0.1, 1.0)
Utah 7 11.5 (10.9, 12.1) 48 (40, 49) 317 rising rising trend 1.4 (1.0, 1.9)
Wyoming 6 11.3 (10.2, 12.5) 49 (30, 49) 83 stable stable trend 0.9 (-0.4, 2.4)
Indiana 6
data not available
N/A
data not available
data not available
data not available
Nevada 6
data not available
N/A
data not available
data not available
data not available
Puerto Rico 6 8.3 (8.0, 8.7) N/A 365 stable stable trend 0.1 (-4.8, 5.2)
Notes:
Created by statecancerprofiles.cancer.gov on 04/24/2024 9:21 pm.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
‡ Incidence data come from different sources. Due to different years of data availability, most of the trends are AAPCs based on APCs but some are APCs calculated in SEER*Stat. Please refer to the source for each area for additional information.

Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Data not available for this combination of data selections.

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.
5 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2022 submission).
7 Source: SEER November 2022 submission.
8 Source: Incidence data provided by the SEER Program. AAPCs are calculated by the Joinpoint Regression Program and are based on APCs. Data are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84,85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Population counts for denominators are based on Census populations as modifed by NCI. The US Population Data File is used with SEER November 2022 data.
Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top